Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Stephen Oxley bought 27 shares of the company’s stock in a transaction dated Wednesday, February 19th. The shares were acquired at an average cost of GBX 1,451 ($18.33) per share, with a total value of £391.77 ($494.97).
Stephen Oxley also recently made the following trade(s):
- On Wednesday, November 27th, Stephen Oxley bought 7,407 shares of Johnson Matthey stock. The shares were acquired at an average cost of GBX 1,343 ($16.97) per share, with a total value of £99,476.01 ($125,680.37).
Johnson Matthey Trading Up 1.0 %
Shares of JMAT stock opened at GBX 1,463.22 ($18.49) on Friday. The company’s 50-day moving average price is GBX 1,384.37 and its 200-day moving average price is GBX 1,478.99. The company has a current ratio of 1.45, a quick ratio of 0.76 and a debt-to-equity ratio of 62.73. The stock has a market cap of £2.45 billion, a price-to-earnings ratio of 24.86, a PEG ratio of 49,242.50 and a beta of 0.95. Johnson Matthey PLC has a twelve month low of GBX 1,295.54 ($16.37) and a twelve month high of GBX 1,917.07 ($24.22).
Johnson Matthey Cuts Dividend
The business also recently announced a dividend, which was paid on Tuesday, February 4th. Shareholders of record on Thursday, December 5th were given a GBX 22 ($0.28) dividend. The ex-dividend date was Thursday, December 5th. This represents a yield of 1.47%. Johnson Matthey’s payout ratio is currently 130.84%.
Analyst Upgrades and Downgrades
JMAT has been the subject of a number of research reports. Berenberg Bank dropped their target price on shares of Johnson Matthey from GBX 1,650 ($20.85) to GBX 1,500 ($18.95) and set a “hold” rating for the company in a report on Thursday, November 28th. Jefferies Financial Group reissued a “buy” rating and set a GBX 1,800 ($22.74) price target on shares of Johnson Matthey in a research report on Tuesday, December 17th.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Recommended Stories
- Five stocks we like better than Johnson Matthey
- The 3 Best Fintech Stocks to Buy Now
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Consumer Discretionary Stocks Explained
- DuPont’s Electronics Spinoff: The Start of Something Big
- 10 Best Airline Stocks to Buy
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.